Scopolamine is an alkaloid drug extracted from a plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergic. Scopolamine is a tropane alkaloid isolated from members of the Solanaceae family of plants, similar to atropine and hyoscyamine, all of which structurally mimic the natural neurotransmitter acetylcholine. It works by blocking the activity of the neurotransmitter acetylcholine, which stimulates the part of the brain that triggers nausea and vomiting, involuntary muscle movement in the lungs, and the gastrointestinal and urinary tracts. Scopolamine is also used in medicine as a sedative or hypnotic and sometimes with morphine to relieve pain. Scopolamine has also been prescribed ‘off label’ for depression, asthma, as a smoking-cessation remedy, and to relieve the nausea that accompanies chemotherapy

Market Dynamics

Scopolamine is effective in reducing depression and anxiety symptoms due to its anxiety-reducing (anxiolytic) effects. Thus the increasing number of people suffering from anxiety is expected to drive the market growth over the forecast period. For instance, according to the Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S. affecting about 40 million adults aged 18 years and older, or 18.1% of the population every year in the U.S.

Moreover, increasing adoption of drug delivery systems such as transdermal patches is expected to drive the market growth over the forecast period. The scopolamine transdermal skin patch is used to prevent nausea and vomiting caused by motion sickness or recovery from anesthesia and surgery.

Key features of the study:

• This report provides in-depth analysis of the global scopolamine API market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global scopolamine API market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Phytex Australia., Aspen Holdings, LGM Pharma, Midas Pharma GmbH, Transo-Pharm Handels-GmbH, Aktin Chemicals,Inc, Merck KgaA, Alchem International Pvt. Ltd., Tiefenbacher API + Ingredients GmbH & Co. KG, Spectrum Chemical, Vital Laboratories Pvt Ltd, Clearsynth, Prism Industries Ltd, Alkaloids Corporation., and Manus Aktteva Biopharma LLP
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global scopolamine API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global scopolamine API market

Detailed Segmentation:

• Global Scopolamine API Market, By Form:
  • Powder 
  • Liquid 
• Global Scopolamine API Market, By Purity:
  • ≥99%
  • ≥ 98% 
• Global Scopolamine API Market, By Scale of Production:
  • Industrial scale
  • Pilot scale 
  • Laboratory scale 
• Global Scopolamine API Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Phytex Australia.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Aspen Holdings
  • LGM Pharma
  • Midas Pharma GmbH
  • Transo-Pharm Handels-GmbH
  • Aktin Chemicals,Inc
  • Merck KGaA
  • Alchem International Pvt. Ltd.
  • Tiefenbacher API + Ingredients GmbH & Co. KG
  • Spectrum Chemical
  • Vital Laboratories Pvt Ltd
  • Clearsynth
  • Prism Industries Ltd
  • Alkaloids Corporation.
  • Manus Aktteva Biopharma LLP

“*” marked represents similar segmentation in other categories in the respective section.